44 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential https://www.fool.com/investing/2024/04/20/missed-out-eli-lilly-and-novo-nordisk-this-small/?source=iedfolrf0000001 Apr 20, 2024 - Altimmune has a modest market cap but an incredibly promising GLP-1 drug.
Eli Lilly Just Announced More Good News: Time to Buy? https://www.fool.com/investing/2024/04/28/eli-lilly-just-announced-more-good-news-time-to-bu/?source=iedfolrf0000001 Apr 28, 2024 - There's no stopping this high-flying biotech.
Eli Lilly (LLY) Stock Declines While Market Improves: Some Information for Investors https://www.zacks.com/stock/news/2203352/eli-lilly-lly-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2203352 Dec 28, 2023 - The latest trading day saw Eli Lilly (LLY) settling at $580.85, representing a -0.11% change from its previous close.
Top Research Reports for Amazon.com, Berkshire Hathaway & Eli Lilly https://www.zacks.com/commentary/2204956/top-research-reports-for-amazon-com-berkshire-hathaway-eli-lilly?cid=CS-ZC-FT-research_daily-2204956 Jan 03, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Berkshire Hathaway Inc. (BRK.B) and Eli Lilly and Company (LLY).
Top Analyst Reports for Eli Lilly, Linde & NextEra Energy https://www.zacks.com/commentary/2211986/top-analyst-reports-for-eli-lilly-linde-nextera-energy?cid=CS-ZC-FT-research_daily-2211986 Jan 18, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Linde plc (LIN) and NextEra Energy, Inc. (NEE).
Top Stock Reports for Eli Lilly, Danaher & Citigroup https://www.zacks.com/commentary/2220146/top-stock-reports-for-eli-lilly-danaher-citigroup?cid=CS-ZC-FT-research_daily-2220146 Feb 02, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Danaher Corporation (DHR) and Citigroup Inc. (C).
ETFs to Buy as Mounjaro Powers Eli Lilly's Q4 Earnings Beat https://www.zacks.com/stock/news/2222669/etfs-to-buy-as-mounjaro-powers-eli-lilly-s-q4-earnings-beat?cid=CS-ZC-FT-etf_news_and_commentary-2222669 Feb 07, 2024 - Eli Lilly and Company (LLY) posted robust fourth-quarter 2023 earnings, beating estimates on both the top and bottom lines driven by strong sales of its diabetes and weight-loss treatments.
Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts https://www.zacks.com/stock/news/2256381/eli-lilly-lly-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2256381 Apr 16, 2024 - In the closing of the recent trading day, Eli Lilly (LLY) stood at $749.26, denoting a -0.2% change from the preceding trading day.
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts https://www.zacks.com/stock/news/2259608/eli-lilly-lly-advances-but-underperforms-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2259608 Apr 22, 2024 - Eli Lilly (LLY) concluded the recent trading session at $731.33, signifying a +0.69% move from its prior day's close.
Eli Lilly (LLY) Rises Higher Than Market: Key Facts https://www.zacks.com/stock/news/2195769/eli-lilly-lly-rises-higher-than-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2195769 Dec 08, 2023 - The latest trading day saw Eli Lilly (LLY) settling at $598.05, representing a +1.66% change from its previous close.

Pages: 12345

<<<Page 4